Physician
Columbia ST. Mary's Hospital Milwaukee, INC
Columbia ST. Mary's Hospital Milwaukee, INC was paid $9.82M by Medicaid between Jan 2018 and Dec 2024, across 190 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoCOLUMBIA ST. MARY'S HOSPITAL MILWAUKEE, INC
MILWAUKEE, WI 53211
MILWAUKEE, WI 53211
33aNPI1023064482assigned 05/26/2006
33bProvider typeFamily Medicine Physician
28Total paid$9.82M
24GClaims442,614
24DCodes billed190
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Wisconsin
Rank by total paid#4 of 359
Median peer was paid$4K
This provider vs. median2,525×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MCCULLOUGH, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,985 | $1.44M | |
| 2019 | 76,166 | $1.39M | |
| 2020 | 62,722 | $1.31M | |
| 2021 | 74,109 | $1.51M | |
| 2022 | 60,625 | $1.40M | |
| 2023 | 59,482 | $1.43M | |
| 2024incomplete | 37,525 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 127,020 | 110,569 | $4.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 67,899 | 58,657 | $1.59M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 8,759 | 7,714 | $489K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4.2% | 70,498 | 55,077 | $413K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 6,113 | 5,733 | $347K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.8% | 8,798 | 8,029 | $271K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.0% | 2,501 | 2,281 | $201K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 4,125 | 3,725 | $152K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.4% | 7,247 | 1,811 | $135K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.2% | 4,103 | 3,416 | $121K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 1,921 | 1,842 | $112K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.1% | 4,130 | 3,880 | $111K |
178 more codes
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,470 | $85K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,709 | $83K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 984 | $82K |
| 11721 | <1% | 8,207 | $81K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,180 | $80K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,006 | $71K |
| 90686 | <1% | 7,339 | $69K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,191 | $59K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,916 | $59K |
| 99000 | <1% | 17,345 | $49K | |
| 93356 | <1% | 2,741 | $46K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,130 | $43K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,127 | $41K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,476 | $38K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,331 | $31K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 891 | $30K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 509 | $24K |
| 3008F | <1% | 2,783 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,802 | $23K |
| 95886 | <1% | 291 | $21K | |
| 80305 | <1% | 1,786 | $20K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 776 | $20K |
| 93296 | <1% | 2,086 | $19K | |
| 90670 | <1% | 4,404 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 431 | $18K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 314 | $18K |
| 80061 | Lipid panel | <1% | 1,385 | $18K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 64 | $18K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 335 | $17K |
| 95720 | <1% | 176 | $16K | |
| 16020 | <1% | 841 | $16K | |
| 90648 | <1% | 3,121 | $15K | |
| 11056 | <1% | 1,161 | $14K | |
| 11057 | <1% | 780 | $14K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 361 | $13K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 13 | $13K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 9,927 | $13K |
| 93298 | <1% | 979 | $12K | |
| 90723 | <1% | 2,473 | $12K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 1,370 | $11K |
| 92557 | <1% | 520 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 98 | $11K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 239 | $10K |
| 99243 | <1% | 172 | $10K | |
| 93295 | <1% | 410 | $8K | |
| 0002A | <1% | 235 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 242 | $8K |
| 31575 | <1% | 144 | $8K | |
| 90680 | <1% | 1,644 | $8K | |
| 80053 | Comprehensive metabolic panel | <1% | 736 | $7K |
| 95971 | <1% | 379 | $7K | |
| 93042 | <1% | 2,175 | $7K | |
| 59025 | Fetal non-stress test | <1% | 309 | $7K |
| 95819 | <1% | 371 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 259 | $7K |
| 77427 | <1% | 82 | $7K | |
| 0001A | <1% | 227 | $7K | |
| 90656 | <1% | 333 | $6K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 477 | $6K |
| 95974 | <1% | 61 | $5K | |
| 93018 | <1% | 544 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 137 | $5K |
| 90750 | <1% | 33 | $5K | |
| 90461 | <1% | 5,297 | $4K | |
| 36224 | <1% | 18 | $4K | |
| 90715 | <1% | 139 | $4K | |
| 90633 | <1% | 617 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 66 | $4K |
| 93294 | <1% | 460 | $4K | |
| 88141 | <1% | 177 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 173 | $3K |
| 76377 | <1% | 126 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 15 | $3K |
| 93299 | <1% | 48 | $3K | |
| 99385 | <1% | 62 | $3K | |
| 90647 | <1% | 527 | $3K | |
| 99442 | <1% | 313 | $3K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $3K |
| 90677 | <1% | 208 | $3K | |
| 93000 | <1% | 270 | $3K | |
| 87070 | <1% | 234 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 324 | $2K |
| 99152 | <1% | 141 | $2K | |
| 98929 | <1% | 50 | $2K | |
| 83655 | <1% | 165 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 33 | $2K |
| 52000 | <1% | 12 | $2K | |
| 99254 | <1% | 34 | $2K | |
| 93016 | <1% | 143 | $2K | |
| 90674 | <1% | 85 | $2K | |
| 99242 | <1% | 40 | $2K | |
| 81003 | <1% | 931 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 126 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 56 | $2K |
| 99460 | <1% | 21 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 58 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 26 | $2K |
| 76376 | <1% | 279 | $1K | |
| 76820 | <1% | 64 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 157 | $1K |
| 94729 | <1% | 299 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 84 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 571 | $1K |
| 90710 | <1% | 98 | $1K | |
| 94060 | <1% | 158 | $1K | |
| 94727 | <1% | 183 | $1K | |
| 96127 | <1% | 284 | $981.76 | |
| 81025 | <1% | 142 | $944.57 | |
| 80081 | <1% | 12 | $882.67 | |
| 90685 | <1% | 285 | $877.43 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 69 | $870.61 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 60 | $838.76 |
| 99407 | <1% | 349 | $802.40 | |
| 90662 | <1% | 31 | $772.50 | |
| 86803 | <1% | 55 | $732.12 | |
| 85027 | <1% | 105 | $705.54 | |
| 73630 | <1% | 36 | $704.01 | |
| 31231 | <1% | 13 | $678.17 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,547 | $629.70 |
| 20611 | <1% | 16 | $604.28 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 42 | $594.02 |
| 20610 | <1% | 17 | $578.75 | |
| 99443 | <1% | 20 | $562.28 | |
| 96132 | <1% | 25 | $545.36 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 96 | $541.91 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $539.25 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 19 | $521.82 |
| 0072A | <1% | 13 | $478.92 | |
| 94726 | <1% | 70 | $465.42 | |
| 95806 | <1% | 12 | $440.03 | |
| 0124A | <1% | 13 | $433.88 | |
| 90480 | <1% | 16 | $433.12 | |
| 80050 | General health panel | <1% | 13 | $423.88 |
| 96133 | <1% | 16 | $416.40 | |
| 90734 | <1% | 28 | $402.15 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 47 | $400.74 |
| 94690 | <1% | 77 | $400.20 | |
| 90651 | <1% | 73 | $389.85 | |
| 99188 | <1% | 32 | $385.07 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $382.33 |
| 83037 | <1% | 128 | $381.24 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 130 | $368.49 |
| 90696 | <1% | 25 | $354.00 | |
| 11720 | <1% | 61 | $348.09 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $330.10 |
| 90681 | <1% | 100 | $299.65 | |
| 95977 | <1% | 16 | $272.26 | |
| 87077 | <1% | 28 | $247.35 | |
| 99406 | <1% | 47 | $241.57 | |
| 69210 | <1% | 29 | $221.35 | |
| 96161 | <1% | 70 | $215.81 | |
| 87081 | <1% | 26 | $210.76 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 16 | $184.24 |
| 92567 | <1% | 14 | $164.26 | |
| 82950 | <1% | 28 | $157.17 | |
| 99441 | <1% | 56 | $133.63 | |
| 93280 | <1% | 18 | $121.19 | |
| 76937 | <1% | 15 | $120.12 | |
| 51798 | <1% | 14 | $106.82 | |
| 96136 | <1% | 15 | $101.84 | |
| 93040 | <1% | 12 | $98.01 | |
| 87147 | <1% | 13 | $77.00 | |
| 84460 | <1% | 14 | $57.21 | |
| 84450 | <1% | 14 | $55.85 | |
| 81001 | <1% | 16 | $55.38 | |
| 85018 | <1% | 12 | $32.41 | |
| 85014 | <1% | 12 | $31.41 | |
| 93325 | <1% | 17 | $30.77 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $26.50 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,035 | $13.11 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 34 | $2.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 617 | $1.67 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $1.12 |
| 91300 | <1% | 516 | $0.74 | |
| 91312 | <1% | 12 | $0.03 | |
| 0500F | 0% | 12 | $0.00 | |
| 91307 | 0% | 17 | $0.00 | |
| 0502F | 0% | 659 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCULLOUGH, MICHAEL (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.